{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:46:54Z","timestamp":1777006014382,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11011-021-00718-3","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:17:14Z","timestamp":1617257834000},"page":"1213-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia"],"prefix":"10.1007","volume":"36","author":[{"given":"Harun","family":"Bayrak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u0131lmaz","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asbur\u00e7e","family":"Olga\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7i\u011fdem Seher","family":"Kasapkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynur","family":"K\u00fc\u00e7\u00fckcongar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"Zenciro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"718_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/0883073810389041","volume":"26","author":"S Aburahma","year":"2011","unstructured":"Aburahma S, Khassawneh M, Griebel M, Sharp G, Gibson J (2011) Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy. J Child Neurol 26:703\u2013706. https:\/\/doi.org\/10.1177\/0883073810389041","journal-title":"J Child Neurol"},{"key":"718_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1023\/b:boli.0000031222.38328.59","volume":"27","author":"DA Applegarth","year":"2004","unstructured":"Applegarth DA, Toone JR (2004) Glycine encephalopathy (nonketotic hyperglycinaemia): review and update. J Inherit Metab Dis 27:417\u2013422. https:\/\/doi.org\/10.1023\/b:boli.0000031222.38328.59","journal-title":"J Inherit Metab Dis"},{"key":"718_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ajmg.a.31030","volume":"140","author":"DA Applegarth","year":"2006","unstructured":"Applegarth DA, Toone JR (2006) Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations. Am J Med Genet A 140:186\u2013188. https:\/\/doi.org\/10.1002\/ajmg.a.31030","journal-title":"Am J Med Genet A"},{"key":"718_CR4","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","volume":"105","author":"DA Applegarth","year":"2000","unstructured":"Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996. Pediatrics 105:e10. https:\/\/doi.org\/10.1542\/peds.105.1.e10","journal-title":"Pediatrics"},{"key":"718_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/jhg.2014.69","volume":"59","author":"NA Azize","year":"2014","unstructured":"Azize NA, Ngah WZ, Othman Z, Ngah WZ, Othman Z, Desa N, Chin BC et al (2014) Mutation analysis of glycine decarboxylase, aminomethyltransferase and glycine cleavage system protein-H genes in 13 unrelated families with glycine encephalopathy. J Hum Genet 59:593\u2013597. https:\/\/doi.org\/10.1038\/jhg.2014.69","journal-title":"J Hum Genet"},{"key":"718_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/brain\/awt328","volume":"137","author":"PR Baker II","year":"2014","unstructured":"Baker PR II, Friederich MW, Swanson MA, Shaikh T, Bhattacharya K, Scharer GH, Aicher J et al (2014) Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5. Brain 137:366\u2013379. https:\/\/doi.org\/10.1093\/brain\/awt328","journal-title":"Brain"},{"key":"718_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/humu.23208","volume":"38","author":"I Bravo-Alonso","year":"2017","unstructured":"Bravo-Alonso I, Navarrete R, Arribas-Carreira L, Perona A, Abia D, Couce ML, Garcia-Cazorla A et al (2017) Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease. Hum Mutat 38:678\u2013691. https:\/\/doi.org\/10.1002\/humu.23208","journal-title":"Hum Mutat"},{"key":"718_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pedneo.2015.10.008","volume":"57","author":"CF Chiu","year":"2016","unstructured":"Chiu CF, Lin JL, Lin JJ, Tseng MH, Lo FS, Chiang MC (2016) Nonketotic Hyperglycinemia of Infants in Taiwan. Pediatr Neonatol 57:420\u2013426. https:\/\/doi.org\/10.1016\/j.pedneo.2015.10.008","journal-title":"Pediatr Neonatol"},{"key":"718_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10545-006-0202-6","volume":"29","author":"C Conter","year":"2006","unstructured":"Conter C, Rolland MO, Cheillan D, Bonnet V, Maire I, Froissart R (2006) Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy. J Inherit Metab Dis 29:135\u2013142. https:\/\/doi.org\/10.1007\/s10545-006-0202-6","journal-title":"J Inherit Metab Dis"},{"key":"718_CR10","doi-asserted-by":"publisher","unstructured":"Coughlin CR II, Swanson MA, Kronquist K, Acquaviva C, Hutchin T, Rodr\u00edguez-Pombo P, V\u00e4is\u00e4nen ML et al (2017) The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT [published correction appears in Genet Med. 2018 Jan 04;:]. Genet Med 19:104-111. https:\/\/doi.org\/10.1038\/gim.2016.74","DOI":"10.1038\/gim.2016.74"},{"key":"718_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ejpn.2011.12.015","volume":"16","author":"R Cusmai","year":"2012","unstructured":"Cusmai R, Martinelli D, Moavero R, Carlo Dionisi Vici CD, Vigevano F, Castana C, Elia M, Bernabei S, Bevivino E (2012) Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia. Eur J Paediatr Neurol 16:509\u2013513. https:\/\/doi.org\/10.1016\/j.ejpn.2011.12.015","journal-title":"Eur J Paediatr Neurol"},{"key":"718_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2005.07.016","volume":"86","author":"A Dinopoulos","year":"2005","unstructured":"Dinopoulos A, Matsubara Y, Kure S (2005) Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab 86:61\u201369. https:\/\/doi.org\/10.1016\/j.ymgme.2005.07.016","journal-title":"Mol Genet Metab"},{"key":"718_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.braindev.2018.06.007","volume":"40","author":"\u00c7 Gen\u00e7 Sel","year":"2018","unstructured":"Gen\u00e7 Sel \u00c7, K\u0131l\u0131\u00e7 M, Y\u00fcksel D, Aksoy A, Kasapkara CS, Ceylaner S, Karli-Oguz K (2018) Nonketotic hyperglycinemia: Clinical range and outcome of a rare neurometabolic disease in a single-center. Brain Dev 40:865\u2013875. https:\/\/doi.org\/10.1016\/j.braindev.2018.06.007","journal-title":"Brain Dev"},{"key":"718_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10545-011-9398-1","volume":"35","author":"JB Hennermann","year":"2012","unstructured":"Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL (2012) Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis 35:253\u2013261. https:\/\/doi.org\/10.1007\/s10545-011-9398-1","journal-title":"J Inherit Metab Dis"},{"key":"718_CR15","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1212\/01.wnl.0000144270.83080.29","volume":"63","author":"JE Hoover-Fong","year":"2004","unstructured":"Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, Hamosh A (2004) Natural history of nonketotic hyperglycinemia in 65 patients. Neurology 63:1847\u20131853. https:\/\/doi.org\/10.1212\/01.wnl.0000144270.83080.29","journal-title":"Neurology"},{"key":"718_CR16","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1136\/jmg.2006.043448","volume":"44","author":"J Kanno","year":"2007","unstructured":"Kanno J, Hutchin T, Kamada F, Narisawa A, Aoki Y, Matsubara Y, Kure S (2007) Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia. J Med Genet 44:e69. https:\/\/doi.org\/10.1136\/jmg.2006.043448","journal-title":"J Med Genet"},{"key":"718_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41430-018-0286-8","volume":"73","author":"MP Kava","year":"2019","unstructured":"Kava MP, Robertson A, Greed L, Balasubramaniam S (2019) Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report. Eur J Clin Nutr 73:961\u2013965. https:\/\/doi.org\/10.1038\/s41430-018-0286-8","journal-title":"Eur J Clin Nutr"},{"key":"718_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1017\/s0012162201002808","volume":"44","author":"SH Korman","year":"2002","unstructured":"Korman SH, Gutman A (2002) Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia). Dev Med Child Neurol 44:712\u2013720. https:\/\/doi.org\/10.1017\/s0012162201002808","journal-title":"Dev Med Child Neurol"},{"key":"718_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1172\/JCI115831","volume":"90","author":"S Kure","year":"1992","unstructured":"Kure S, Takayanagi M, Narisawa K, Tada K, Leisti J (1992) Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. J Clin Invest 90:160\u2013164. https:\/\/doi.org\/10.1172\/JCI115831","journal-title":"J Clin Invest"},{"key":"718_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/(sici)1097-0223(199908)19:8<717::aid-pd625>3.0.co;2-l","volume":"19","author":"S Kure","year":"1999","unstructured":"Kure S, Rolland MO, Leisti J, Mandel H, Sakata Y, Tada K, Matsubara Y, et al (1999) Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenat Diagn 19:717\u2013720. doi: https:\/\/doi.org\/10.1002\/(sici)1097-0223(199908)19:8<717::aid-pd625>3.0.co;2-l.","journal-title":"Prenat Diagn"},{"key":"718_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/humu.20293","volume":"27","author":"S Kure","year":"2006","unstructured":"Kure S, Kato K, Dinopoulos A, Gail C, deGrauw TJ, Christodoulou J, Bzduch V et al (2006) Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia. Hum Mutat 27:343\u2013352. https:\/\/doi.org\/10.1002\/humu.20293","journal-title":"Hum Mutat"},{"key":"718_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1542\/peds.71.4.581","volume":"71","author":"R Matalon","year":"1983","unstructured":"Matalon R, Naidu S, Hughes JR, Michals K (1983) Nonketotic hyperglycinemia: treatment with diazepam\u2013a competitor for glycine receptors. Pediatrics 71:581\u2013584","journal-title":"Pediatrics"},{"key":"718_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00234-017-1913-0","volume":"59","author":"SA Mohammad","year":"2017","unstructured":"Mohammad SA, Abdelkhalek HS (2017) Nonketotic hyperglycinemia: spectrum of imaging findings with emphasis on diffusion-weighted imaging. Neuroradiology 59:1155\u20131163. https:\/\/doi.org\/10.1007\/s00234-017-1913-0","journal-title":"Neuroradiology"},{"key":"718_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/BF00201565","volume":"93","author":"K Nanao","year":"1994","unstructured":"Nanao K, Okamura-Ikeda K, Motokawa Y, Danks DM, Baumgartner ER, Takada G, Hayasaka K (1994) Identification of the mutations in the T-protein gene causing typical and atypical nonketotic hyperglycinemia. Hum Genet 93:655\u2013658. https:\/\/doi.org\/10.1007\/BF00201565","journal-title":"Hum Genet"},{"key":"718_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712489","author":"F Nasrallah","year":"2020","unstructured":"Nasrallah F, Hadj-Taieb S, Chehida AB, Jelassi A, Massoued SB, Charfi M, Zidi W et al (2020) Nonketotic Hyperglycinemia in Tunisia. Report upon a Series of 69 Patients. Neuropediatrics. https:\/\/doi.org\/10.1055\/s-0040-1712489","journal-title":"Neuropediatrics"},{"key":"718_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW et al (2015) ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"718_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5144\/0256-4947.2004.378","volume":"24","author":"D Roy","year":"2004","unstructured":"Roy D, Al-Asmari A, Ghazal YK, Al-Oqiel S (2004) Nonketotic hyperglycinemia in Suleimaniah Children\u2019s Hospital, Riyadh, Saudi Arabia. Ann Saudi Med 24:378\u2013381. https:\/\/doi.org\/10.5144\/0256-4947.2004.378","journal-title":"Ann Saudi Med"},{"key":"718_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0039-1692207","volume":"50","author":"RM Shbarou","year":"2019","unstructured":"Shbarou RM, Boustany RM, Daher RT, Pakdel P, Noureddine A, Karam PE (2019) Outcome of nonketotic hyperglycinemia in Lebanon: 14-year retrospective review. Neuropediatrics 50:235\u2013243. https:\/\/doi.org\/10.1055\/s-0039-1692207","journal-title":"Neuropediatrics"},{"key":"718_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3345\/kjp.2012.55.8.301","volume":"55","author":"JH Shin","year":"2012","unstructured":"Shin JH, Ahn SY, Shin JH, Sung SI, Jung JM, Kim JK, Kim ES et al (2012) Sequential magnetic resonance spectroscopic changes in a patient with nonketotic hyperglycinemia. Korean J Pediatr 55:301\u2013305. https:\/\/doi.org\/10.3345\/kjp.2012.55.8.301","journal-title":"Korean J Pediatr"},{"key":"718_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jimd.12072","volume":"42","author":"NV Stence","year":"2019","unstructured":"Stence NV, Fenton LZ, Levek C, Tong S, Coughlin CR II, Hennermann JB, Wortmann SB et al (2019) Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype. J Inherit Metab Dis 42:438\u2013450. https:\/\/doi.org\/10.1002\/jimd.12072","journal-title":"J Inherit Metab Dis"},{"key":"718_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ana.24485","volume":"78","author":"MA Swanson","year":"2015","unstructured":"Swanson MA, Coughlin CR Jr, Scharer GH, Szerlong HJ, Bjoraker KJ, Spector EB, Creadon-Swindell G et al (2015) Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia [published correction appears in Ann Neurol 2016;79:505]. Ann Neurol 78:606\u2013618. https:\/\/doi.org\/10.1002\/ana.24485","journal-title":"Ann Neurol"},{"key":"718_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1620\/tjem.98.289","volume":"98","author":"K Tada","year":"1969","unstructured":"Tada K, Narisawa K, Yoshida T, Yokoyama K, Nakagawa H, Tanno K, Mochizuk\u0130 K et al (1969) Hyperglycinemia: a defect in glycine cleavage reaction. Tohuku J Exp Med 98:289\u2013296","journal-title":"Tohuku J Exp Med"},{"key":"718_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1006\/mgme.2000.3000","volume":"70","author":"JR Toone","year":"2000","unstructured":"Toone JR, Applegarth DA, Coulter-Mackie MB, James ER (2000) Biochemical and molecular investigations of patients with nonketotic hyperglycinemia. Mol Genet Metab 70:116\u2013121. https:\/\/doi.org\/10.1006\/mgme.2000.3000","journal-title":"Mol Genet Metab"},{"key":"718_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ajmg.1320590410","volume":"59","author":"JL Van Hove","year":"1995","unstructured":"Van Hove JL, Kishnani P, Muenzer J, Wenstrup RJ, Summar ML, Brummond MR, Lachiewicz AM et al (1995) Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. Am J Med Genet 59:444\u2013453. https:\/\/doi.org\/10.1002\/ajmg.1320590410","journal-title":"Am J Med Genet"},{"key":"718_CR35","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/wnl.54.3.754","volume":"54","author":"JL Van Hove","year":"2000","unstructured":"Van Hove JL, Kishnani PS, Demaerel P, Kahler SG, Miller C, Jaeken J, Rutledge SL (2000) Acute hydrocephalus in nonketotic hyperglycinemia. Neurology 54:754\u2013756. https:\/\/doi.org\/10.1212\/wnl.54.3.754","journal-title":"Neurology"},{"key":"718_CR36","unstructured":"Van Hove JLK, Coughlin C II, Swanson M, Hennermann JB (2002) [updated 2019] Nonketotic Hyperglycinemia In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews\u00ae [Internet]. University of Washington, Seattle, 1993\u20132020"},{"key":"718_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10545-005-0033-x","volume":"28","author":"JL Van Hove","year":"2005","unstructured":"Van Hove JL, Vande Kerckhove K, Hennermann JB, Mahieu V, Declercq P, Mertens S, De Becker M et al (2005) Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. J Inherit Metab Dis 28:651\u2013663. https:\/\/doi.org\/10.1007\/s10545-005-0033-x","journal-title":"J Inherit Metab Dis"},{"key":"718_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-3-662-49771-5_23","volume-title":"Inborn Metabolic Diseases, Diagnosis and Treatment","author":"JLK Van Hove","year":"2016","unstructured":"Van Hove JLK, Hennermann JB, Coughlin IICR (2016) Nonketotic Hyperglycinemia (Glycine Encephalopathy) and Lipoate Deficiency Disorders. In: Saudubray JM, Baumgartner MR, Walter J (eds) Inborn Metabolic Diseases, Diagnosis and Treatment, 6th edn. Springer, Berlin, pp 349\u2013357","edition":"6"},{"key":"718_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/0883073812441063","volume":"28","author":"C Ver\u00edssimo","year":"2013","unstructured":"Ver\u00edssimo C, Garcia P, Sim\u00f5es M, Robalo C, Henriques R, Diogo L, Grazina M (2013) Nonketotic hyperglycinemia: a cause of encephalopathy in children. J Child Neurol 28:251\u2013254. https:\/\/doi.org\/10.1177\/0883073812441063","journal-title":"J Child Neurol"},{"key":"718_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1399-0004.1979.tb01773.x","volume":"15","author":"L von Wendt","year":"1979","unstructured":"von Wendt L, Hirvasniemi A, Simil\u00e4 S. Nonketotic hyperglycinemia (1979) A genetic study of 13 Finnish families. Clin Genet 15:411\u2013417. https:\/\/doi.org\/10.1111\/j.1399-0004.1979.tb01773.x","journal-title":"Clin Genet"},{"key":"718_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/a:1005690611675","volume":"23","author":"EJ Wiltshire","year":"2000","unstructured":"Wiltshire EJ, Poplawski NK, Harrison JR, Fletcher JM (2000) Treatment of late-onset nonketotic hyperglycinaemia: effectiveness of imipramine and benzoate. J Inherit Metab Dis 23:15\u201321. https:\/\/doi.org\/10.1023\/a:1005690611675","journal-title":"J Inherit Metab Dis"},{"key":"718_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/archpedi.1986.02140200106038","volume":"140","author":"JA Wolff","year":"1986","unstructured":"Wolff JA, Kulovich S, Yu AL, Qiao CN, Nyhan WL (1986) The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia. Am J Dis Child 140:596\u2013602. https:\/\/doi.org\/10.1001\/archpedi.1986.02140200106038","journal-title":"Am J Dis Child"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00718-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:10:54Z","timestamp":1671765054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00718-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00718-3","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case has not been and will not be published elsewhere in substantially the same form. All\u00a0co-authors reviewed the final approval of the version from prior to submission. All authors have been involved in (a) conception and design, or analysis and interpretation of data and (b) drafting the case or revising it critically for important intellectual content and agree to submission. All authors have provided the information on \u2018Declarations\u2019.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}